| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,448,000 | 4,652,000 | 4,889,000 | 6,703,000 | | Cost of Revenue | 4,175,000 | 3,519,000 | 3,741,000 | 5,355,000 | | | Gross Profit | 1,273,000 | 1,133,000 | 1,148,000 | 1,348,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,022,000 | 975,000 | 904,000 | 1,075,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 251,000 | 158,000 | 244,000 | 273,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 19,000 | 28,000 | 16,000 | 52,000 | | Earnings Before Interest And Taxes | 270,000 | 186,000 | 260,000 | 314,000 | | Interest Expense | 7,000 | 7,000 | 12,000 | 11,000 | | Income Before Tax | 263,000 | 179,000 | 248,000 | 303,000 | | Income Tax Expense | 61,000 | 39,000 | 69,000 | 80,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 199,000 | 142,000 | 177,000 | 225,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 199,000 | 142,000 | 177,000 | 225,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $199,000 | $142,000 | $177,000 | $225,000 |
|
0.01% Nasdaq 0.00%
Income Statement
